Product Information
CELECOXIB 400 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.2480 per EA under NDC 69097042003. Its NADAC has been published 521 times since Oct 12, 2016.
FDA first approved this application on Sep 23, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Cipla USA Inc.NDC
69097042003
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CELECOXIBApproval Type
Generic (ANDA)
FDA Application
ANDA207446FDA Approved
9/23/2015
TE Code
AB
On Market Since
9/23/2015
Pharmacological Classes
Price Statistics
The NADAC for CELECOXIB 400 MG CAPSULE has been published 521 times since Oct 12, 2016, and over the history we have for it it has declined 86.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2480 per EA |
|---|---|
| All-time high | $2.1421 (Mar 15, 2017) |
| All-time low | $0.2055 (Jul 22, 2026) |
| 52-week high | $0.3409 |
| 52-week low | $0.2055 |
| Median price | $0.6508 |
| Average price | $0.7441 |
| Largest weekly change | +54.7% (Jun 22, 2022) |
| Weeks tracked | 521 |
| Tracking since | Oct 12, 2016 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CELECOXIB market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CELECOXIB 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 400 MG CAPSULE, manufactured by Cipla USA Inc., is $0.2480 per EA (NDC 69097042003), effective Sep 30, 2026.
How has the price of CELECOXIB 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CELECOXIB 400 MG CAPSULE has declined 86.4%. It has been tracked across 521 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for CELECOXIB 400 MG CAPSULE?
Since Oct 12, 2016, the NADAC for CELECOXIB 400 MG CAPSULE has ranged from a low of $0.2055 (Jul 22, 2026) to a high of $2.1421 (Mar 15, 2017), with a median of $0.6508 per EA.
Are there cheaper alternatives to CELECOXIB 400 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CELECOXIB 400 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CELECOXIB 400 MG CAPSULE?
CELECOXIB 400 MG CAPSULE (NDC 69097042003) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.